Bank of New York Mellon Corp Cuts Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Bank of New York Mellon Corp lessened its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 22.5% in the 4th quarter, according to its most recent filing with the SEC. The firm ...
Voyager Therapeutics (NASDAQ:VYGR) Given New $12.00 Price Target at Canaccord Genuity Group
Voyager Therapeutics (NASDAQ:VYGR – Free Report) had its price target trimmed by Canaccord Genuity Group from $14.00 to ...
Benzinga.com7d
Voyager Therapeutics Analyst Ratings
The latest price target for Voyager Therapeutics (NASDAQ:VYGR) was reported by Canaccord Genuity on March 13, 2025. The analyst firm set a price target for $12.00 expecting VYGR to rise to within ...
Investing6d
Voyager Therapeutics Inc (VYGR)
AbbVie (NYSE:ABBV) resumed with Buy rating and $103 (8% upside) price target by BofAML. Acorda Therapeutics (NASDAQ:ACOR) resumed... Gainers: CERS +18%. PODD +17%. BIO +16%. ABUS +16%. MOH +15% ...